Great Basin Shareholders Approve Reverse Stock Split | GenomeWeb

NEW YORK (GenomeWeb) – Molecular diagnostics firm Great Basin Scientific announced today that its stockholders have approved a reverse stock split of the company's shares at a ratio of one for 50 to one for 60.

The ratio and timing of the split will be decided by the company's board of directors, Great Basin said. It added that the split would cure a previously announced authorized share failure, allowing Series C warrants to be exercisable for the next 25 trading days pursuant to the amended terms of the warrants disclosed earlier this week. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.